Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Publikationer

Filtrer
Poster

Are patient-reported outcomes useful in post-treatment follow-up care for women with early breast cancer? - A scoping review

Riis, C. L., Bechmann, T., Jensen, P. T., Coulter, A. & Dahl Steffensen, K., 2019.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

A study in optimizing follow up for postmenopausal women with breast cancer treated with adjuvant endocrine therapy

Lundgaard Riis, C., Bechmann, T., Jensen, P. T., Coulter, A. & Dahl Steffensen, K., 29. aug. 2019.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

BoneBio: Breast cancer and bone biomarkers: Poster to abstract #24 BoneBio: The variable sensitivity of breast cancer patients to zoledronic acid

Bidragets oversatte titel: BoneBio: Brystkræft og knogle biomarkørerMarie Julie Møller, A., Bechmann, T., Madsen, J. S., Hugger Jakobsen, E. & Søe, K., 29. aug. 2019, s. 38. 1 s.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Åben adgang

DEVELOPMENT OF A PATIENT DECISION AID TEMPLATE FOR USE IN DIFFERENT CLINICAL SETTINGS

Olling, K., Bechmann, T., Madsen, P. H., Hugger Jakobsen, E., Hilberg, O., Coulter, A. & Dahl Steffensen, K., 30. aug. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Fil
54 Downloads (Pure)

High dose oral vinorelbine and trastuzumab in HER2 positive metastatic breast cancer

Bechmann, T., Madsen, J. S., Luczak, A. A., Gregersen, T. A. & Hugger Jakobsen, E., 2015.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Human osteoclasts generated from different individuals show a highly variable sensitivity to zoledronic acid in vitro – osteoclasts from smokers are less sensitive!

Marie Julie Møller, A., Delaissé, J-M., Bechmann, T., Olesen, J. B., Madsen, J. S., Canto, L. M. D., Hugger Jakobsen, E., Rogatto, S. R. & Søe, K., 31. jan. 2020.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Optimeret opfølgning for brystkræftpatienter i sygehusregi

Riis, C. L., Bechmann, T., Jensen, P. T., Coulter, A. & Dahl Steffensen, K., 18. jan. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Quantitative tissue HER2 protein concentration does not expand the group of patients eligible for adjuvant HER2-targeted therapy

Bechmann, T., Olsen, D. A., Jakobsen, E. H., Madsen, J. S., Brandslund, I., Jylling, A. M. B., Dahl Steffensen, K. & Jakobsen, A., 20. apr. 2012.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Shared decision making in decision on adjuvant radiotherapy for early stage breast cancer patients

Bechmann, T., Ellegaard, M-B. B., Hugger Jakobsen, E., Offersen, B. V., Bøje, C. R., Zachariae, B. & Dahl Steffensen, K., 30. aug. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Åben adgang

The clinical outcome in breast cancer patients with HER2 status determined by a quantitative ELISA technique

Bechmann, T., Jakobsen, E. H., Madsen, J. S., Brandslund, I., Olsen, D. A., Jylling, A. M. B., Dahl Steffensen, K. & Jakobsen, A., 5. maj 2012.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

The clinical significance of quantitative HER2 determination in breast cancer

Bechmann, T., Jakobsen, E. H., Madsen, J. S., Jylling, A. M. B., Dahl Steffensen, K. & Jakobsen, A., 10. mar. 2011.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review